Business Wire

NY-ZOOP

26.5.2022 15:03:12 CEST | Business Wire | Press release

Share
OnlyFans Founder Launching Celebrity Trading Card Platform, Zoop, Backed by Polygon

Led by a robust team of Web3 developers and former OnlyFans executives, Zoop is set to launch their digital collectable trading platform powered by Polygon , the decentralized Ethereum scaling ecosystem. Zoop’s platform allows users to buy, sell, collect and trade 3D digital playing cards of their favorite celebrities.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220526005159/en/

On Zoop, fans can acquire officially licensed, limited edition digital cards, and are able to sell and trade them in a secondary market.

“Zoop is the trusted home for authentic celebrity card drops, enabling all fans, regardless of their technical expertise, to participate in the web3.0 space. We hold users' hands as they compete in acquiring digital collectables in the auction process, show off their holdings to friends and ‘collect-to-connect’ with their favorite celebrities of today and tomorrow. Zoop provides access to communities based on the cards users own, and rewards points to users for their interactions with each other and within these communities. We are excited to be launching Summer 2022,” says RJ Phillips, Founder and co-CEO of Zoop. “It’s a win for the celebrities, creates excitement for the fans and a new way for brands to connect with their customers,” he said.

Zoop is capitalizing on the booming blockchain gamification market, which grew to a $40 billion industry in 2021. And, by 2026, the industry is predicted to grow to $147 billion . By opening up the platform and combining it with today’s influencer-driven creator economy, Zoop’s app allows fans to collect 3D digital trading cards from their favorite influencers and celebrities, fostering a closer connection between fan and influencer. Fans can buy, sell, and trade cards, as well as compete in competitions and challenges to gain points, unlocking special rewards including access to like- minded communities. Zoop’s inclusive ecosystem is creating value for digital trading cards by enabling a fully transparent leaderboard.

The Zoop team will be led by co-CEOs Tim Stokely, tech Entrepreneur and founder of OnlyFans, and RJ Phillips. Tim, who will be joining the team in time for the launch this summer, brings extensive knowledge of the creator economy and a proven track record in building a true tech unicorn while RJ’s expertise in growth and scaling make for the perfect leadership team. Together, Tim and RJ plan to leverage their past career successes and knowledge of the creator economy to ultimately scale Zoop into a global digital trading card ecosystem that drives value for both creators and fans alike.

As a precursor to its initial launch, Zoop is offering a limited number of pre-launch Priority Passes (PP), which reward the earlier adopters with a host of perks, both in-app and real-life, in addition to exclusive airdrops only for PP holders. The first batch of these Priority Passes are available now at mint.zoopcards.com .

Zoop will be building its digital marketplace on the globally recognized Polygon blockchain network. Like Zoop, Polygon believes in Web3 for all, making them an ideal partner and blockchain of choice for the Zoop platform. Their low transaction costs and high security standard make card trading on Zoop safe and accessible for all. Additionally, Polygon’s sustainability commitment to make all their NFTs carbon-negative by the end of 2022 was another important factor for Zoop.

“We're delighted to be working with the Zoop team as they build out their platform on Polygon. Zoop aligns with our mission to bring Web3 technologies to a much broader demographic, and allowing fans to connect to their favorite celebrities via Polygon is another step towards this goal," said Michael Blank, COO of Polygon Studios, who has been providing Zoop with a suite of services such as technical support, Web3 game design and distribution, asset expansion and more.

Zoop's announcement comes just weeks after Instagram began minting their non-fungible tokens (NFTs) on Polygon's carbon-neutral network as well.

About Zoop

Zoop is building an entire ecosystem based on officially licensed celebrity digital trading cards. Fans are easily able to buy, sell, trade and collect the celebrities and influencers they idolize and admire through cutting edge blockchain technology. On Zoop, fans can build out their card collections and earn fan rewards with exclusive celebrity experiences whilst forging communities of like-minded collectors. Zoop cards garner authenticity through official partnerships with an unrivaled roster of celebrities and brands onboard. To learn more visit www.zoopcards.com .

Website | Twitter | Telegram | LinkedIn | Discord | Instagram | Facebook | Mint Page | Support Twitter | Medium | Tim’s Instagram | RJ’s Instagram

About Polygon

Polygon is the leading platform for Ethereum scaling and infrastructure development. Its growing suite of products offers developers easy access to all major scaling and infrastructure solutions: L2 solutions (ZK Rollups and Optimistic Rollups), sidechains, hybrid solutions, stand-alone and enterprise chains, data availability solutions, and more. Polygon’s scaling solutions have seen widespread adoption with 19,000+ applications hosted, 3.4B+ total transactions processed, ~135M+ unique user addresses, and $5B+ in assets secured.

If you're an Ethereum Developer, you're already a Polygon developer! Leverage Polygon’s fast and secure txns for your dApp, get started here .

Website | Twitter | Ecosystem Twitter | Developer Twitter | Studios Twitter | Telegram | LinkedIn | Reddit | Discord | Instagram | Facebook

About Polygon Studios

Polygon Studios aims to be the home of the most popular blockchain projects in the world. The Polygon Studios team is focused on supporting developers building decentralized apps on Polygon by providing Web2 and Web3 teams with a suite of services such as developer support, partnership, strategy, go-to-market, and technical integrations. Polygon Studios supports projects from OpenSea to Prada, from Adidas to Draft Kings and Decentral Games to Ubisoft.

Twitter | Facebook | Instagram | Telegram | Tiktok | LinkedIn

DISCLAIMER: Except where otherwise noted, the information contained in this release is as of May 26, 2022. We assume no obligation to update any forward-looking statements contained in this release as a result of new information or future events or developments. We cannot guarantee that any forward-looking statement will be realized. Should known or unknown risks or uncertainties materialize or should underlying assumptions prove inaccurate, actual results could vary materially from those anticipated, estimated or projected. Readers are cautioned not to put undue reliance on forward-looking statements.

Link:

ClickThru

Social Media:

https://www.facebook.com/zoop.cards

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

IEO and Laife Reply Join Forces to Digitalise the Biobank Through Artificial Intelligence10.2.2026 10:00:00 CET | Press release

The two partners launch “Bianca”, the first large-scale digitalisation initiative in Italy focused on histopathological samples, aimed at training AI algorithms to support pathologists’ diagnostic activities. The Pathology Division of the European Institute of Oncology (IEO) and Laife Reply, the Reply Group company specialised in AI and Big Data solutions for the healthcare sector, have entered into a collaboration to develop Bianca, the first project in Italy aimed at creating an AI-based digital biobank designed as an integral part of clinical diagnostic practice. The initiative is part of a broader technological innovation journey that structurally integrates research and development into routine diagnostic processes in pathology, transforming the traditional histopathological sample workflow into an end-to-end digital ecosystem. The complete digitalisation of histopathological and molecular diagnostic workflows aims to make analysis more efficient, scalable and reproducible, laying

OPEX® Corporation Introduces the Velo™ Series of Premium Desktop and High Production Document Scanners10.2.2026 10:00:00 CET | Press release

OPEX® Corporation, a global leader in Next Generation Automation providing innovative solutions for warehouse, document and mail automation, has announced the launch of its Velo™ Series powered by InoTec, a new class of premium desktop and free standing high production scanners. The OPEX Velo scanners are engineered to deliver exceptional performance, reliability and image quality and offer industry-standard TWAIN/ISIS connectivity to help simplify deployment into existing capture environments. These state-of-the-art scanners are ideal for service bureaus, government agencies, healthcare providers and enterprise capture operations. “The Velo Series powered by InoTec introduces an entirely new class of scanners to the OPEX portfolio, expanding the options available to both our current customers and organizations considering OPEX for the first time,” said Dann Worrell, President, Document and Mail Automation, OPEX. “By broadening our offerings, we can better align the right solution with

New ZOLL Zenix Monitor/Defibrillator Receives MDR Approval10.2.2026 10:00:00 CET | Press release

ZOLL®, an Asahi Kasei company that manufactures medical devices and related software solutions, announced today that Zenix®, the company’s most clinically advanced and easy-to-use professional monitor/defibrillator, is approved under the European Union (EU) Medical Device Regulation 2017/745, commonly referred to as EU MDR. The Zenix monitor/defibrillator is a groundbreaking device that redefines efficiency, clarity, and intelligence in both EMS and hospital settings. Built from years of feedback from customers, Zenix combines intuitive design with powerful functionality to enhance patient care and automate workflows for ease-of-use. Featuring a large, durable touchscreen, Zenix provides critical information when it’s needed. With on-the-fly customization, healthcare professionals can make real-time adjustments, helping them stay in control during high-pressure situations. Equipped with ZOLL’s innovative Real BVM Help® and exclusive Real CPR Help® technology, Zenix gives healthcare pro

Expereo Elevates expereoOne with New Digital Case Management Capabilities, Delivering Faster, Clearer and More Predictable Service Resolution10.2.2026 10:00:00 CET | Press release

Expereo is redefining what’s possible for global enterprises at CiscoLive Amsterdam with the launch of its enhanced Digital Case Management (DCM) capability in expereoOne. As the world-leading managed Network as a Service (NaaS) provider, Expereo is putting customers firmly in control - slashing resolution times, cutting through operational noise and ensuring everyone is aligned every step of the way. With DCM, service issues are no longer bottlenecks: instead, enterprises experience swift, transparent outcomes, with every stakeholder empowered through a single, real-time view of progress. DCM is designed around a simple objective: enable enterprises to resolve issues faster, with greater clarity and full control, through a fully digital, software-first workflow inside expereoOne. Customers can create, manage and track cases end-to-end within a single platform, ensuring predictable, consistent and aligned service experiences across their global network footprint. Unified, digital-first

U.S. Food and Drug Administration Accepts New Drug Application and Grants Priority Review for Takeda’s Oveporexton (TAK-861) as a Potential First-in-Class Therapy for Narcolepsy Type 110.2.2026 09:15:00 CET | Press release

This FDA Acceptance is a Milestone for People Living with Narcolepsy Type 1 Who Need New and Different Treatment OptionsOveporexton is an Orexin Agonist Designed to Restore Orexin Signaling and Address the Underlying Orexin Deficiency that Causes Narcolepsy Type 1The Prescription Drug User Fee Act (PDUFA) Target Action Date is the Third Quarter of this Calendar Year Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) accepted its New Drug Application (NDA) and granted Priority Review for oveporexton (TAK-861) for the treatment of narcolepsy type 1 (NT1). Oveporexton is an investigational oral orexin receptor 2 (OX2R)-selective agonist designed to address the underlying orexin deficiency that causes NT1 by restoring orexin signaling. The FDA has set a Prescription Drug User Fee Act (PDUFA) goal date in the third quarter of this calendar year. Takeda remains on track to potentially bring the first approved orexin agonist treatment to people living

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye